[1]
K. Chowdhury, S. K. Dolui, S. Basu, and A. Sur, “A Comparative Study of Safety and Efficacy of Clopidogrel and Prasugrel in Reducing Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention”, Int. J. Hum. Health Sci., vol. 8, no. 4, pp. 328–334, Nov. 2024.